Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 25 October 2021
EventHumanCOVID-19Vaccines
Date
- Monday, 25 October 2021
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
This extraordinary plenary meeting is organised in the context of the evaluation of an application for the use of a booster dose for the COVID-19 vaccine Spikevax.
The aim of the meeting is to conclude this evaluation, if possible.
The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the Agency's opinions on all questions concerning human medicines.